157 related articles for article (PubMed ID: 25603992)
1. Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study.
Salort-Campana E; Nguyen K; Bernard R; Jouve E; Solé G; Nadaj-Pakleza A; Niederhauser J; Charles E; Ollagnon E; Bouhour F; Sacconi S; Echaniz-Laguna A; Desnuelle C; Tranchant C; Vial C; Magdinier F; Bartoli M; Arne-Bes MC; Ferrer X; Kuntzer T; Levy N; Pouget J; Attarian S
Orphanet J Rare Dis; 2015 Jan; 10():2. PubMed ID: 25603992
[TBL] [Abstract][Full Text] [Related]
2. Type 1 FSHD with 6-10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention.
Salort-Campana E; Fatehi F; Beloribi-Djefaflia S; Roche S; Nguyen K; Bernard R; Cintas P; Solé G; Bouhour F; Ollagnon E; Sacconi S; Echaniz-Laguna A; Kuntzer T; Levy N; Magdinier F; Attarian S
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210100
[TBL] [Abstract][Full Text] [Related]
3. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.
Ricci G; Scionti I; Sera F; Govi M; D'Amico R; Frambolli I; Mele F; Filosto M; Vercelli L; Ruggiero L; Berardinelli A; Angelini C; Antonini G; Bucci E; Cao M; Daolio J; Di Muzio A; Di Leo R; Galluzzi G; Iannaccone E; Maggi L; Maruotti V; Moggio M; Mongini T; Morandi L; Nikolic A; Pastorello E; Ricci E; Rodolico C; Santoro L; Servida M; Siciliano G; Tomelleri G; Tupler R
Brain; 2013 Nov; 136(Pt 11):3408-17. PubMed ID: 24030947
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy.
Ruggiero L; Mele F; Manganelli F; Bruzzese D; Ricci G; Vercelli L; Govi M; Vallarola A; Tripodi S; Villa L; Di Muzio A; Scarlato M; Bucci E; Antonini G; Maggi L; Rodolico C; Tomelleri G; Filosto M; Previtali S; Angelini C; Berardinelli A; Pegoraro E; Moggio M; Mongini T; Siciliano G; Santoro L; Tupler R
JAMA Netw Open; 2020 May; 3(5):e204040. PubMed ID: 32356886
[TBL] [Abstract][Full Text] [Related]
5. A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.
Wohlgemuth M; Lemmers RJ; Jonker M; van der Kooi E; Horlings CG; van Engelen BG; van der Maarel SM; Padberg GW; Voermans NC
Neurology; 2018 Jul; 91(5):e444-e454. PubMed ID: 29997197
[TBL] [Abstract][Full Text] [Related]
6. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.
Mul K; Voermans NC; Lemmers RJLF; Jonker MA; van der Vliet PJ; Padberg GW; van Engelen BGM; van der Maarel SM; Horlings CGC
Clin Genet; 2018 Dec; 94(6):521-527. PubMed ID: 30211448
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and molecular diagnosis of facioscapulohumeral dystrophy type 1 (FSHD1) in 2012].
Salort-Campana E; Nguyen K; Lévy N; Pouget J; Attarian S
Rev Neurol (Paris); 2013; 169(8-9):573-82. PubMed ID: 24011979
[TBL] [Abstract][Full Text] [Related]
8. Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2.
Lemmers RJLF; van der Vliet PJ; Vreijling JP; Henderson D; van der Stoep N; Voermans N; van Engelen B; Baas F; Sacconi S; Tawil R; van der Maarel SM
Hum Mol Genet; 2018 Oct; 27(20):3488-3497. PubMed ID: 30281091
[TBL] [Abstract][Full Text] [Related]
9. Case report: Identification of facioscapulohumeral muscular dystrophy 1 in two siblings with normal phenotypic parents using optical genome mapping.
Jiang J; Cai X; Qu H; Yao Q; He T; Yang M; Zhou H; Zhang X
Front Neurol; 2024; 15():1258831. PubMed ID: 38361638
[TBL] [Abstract][Full Text] [Related]
10. Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry.
Nikolic A; Ricci G; Sera F; Bucci E; Govi M; Mele F; Rossi M; Ruggiero L; Vercelli L; Ravaglia S; Brisca G; Fiorillo C; Villa L; Maggi L; Cao M; D'Amico MC; Siciliano G; Antonini G; Santoro L; Mongini T; Moggio M; Morandi L; Pegoraro E; Angelini C; Di Muzio A; Rodolico C; Tomelleri G; Grazia D'Angelo M; Bruno C; Berardinelli A; Tupler R
BMJ Open; 2016 Jan; 6(1):e007798. PubMed ID: 26733561
[TBL] [Abstract][Full Text] [Related]
11. A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere.
Thomas NS; Wiseman K; Spurlock G; MacDonald M; Ustek D; Upadhyaya M
J Med Genet; 2007 Mar; 44(3):215-8. PubMed ID: 16987949
[TBL] [Abstract][Full Text] [Related]
12. FSHD1 and FSHD2 form a disease continuum.
Sacconi S; Briand-Suleau A; Gros M; Baudoin C; Lemmers RJLF; Rondeau S; Lagha N; Nigumann P; Cambieri C; Puma A; Chapon F; Stojkovic T; Vial C; Bouhour F; Cao M; Pegoraro E; Petiot P; Behin A; Marc B; Eymard B; Echaniz-Laguna A; Laforet P; Salviati L; Jeanpierre M; Cristofari G; van der Maarel SM
Neurology; 2019 May; 92(19):e2273-e2285. PubMed ID: 30979860
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of facioscapulohumeral muscular dystrophy 2.
de Greef JC; Lemmers RJ; Camaño P; Day JW; Sacconi S; Dunand M; van Engelen BG; Kiuru-Enari S; Padberg GW; Rosa AL; Desnuelle C; Spuler S; Tarnopolsky M; Venance SL; Frants RR; van der Maarel SM; Tawil R
Neurology; 2010 Oct; 75(17):1548-54. PubMed ID: 20975055
[TBL] [Abstract][Full Text] [Related]
14. Facioscapulohumeral muscular dystrophy.
Sacconi S; Salviati L; Desnuelle C
Biochim Biophys Acta; 2015 Apr; 1852(4):607-14. PubMed ID: 24882751
[TBL] [Abstract][Full Text] [Related]
15. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of single-molecule optical mapping to a multigeneration FSHD1 pedigree.
Zhang Q; Xu X; Ding L; Li H; Xu C; Gong Y; Liu Y; Mu T; Leigh D; Cram DS; Tang S
Mol Genet Genomic Med; 2019 Mar; 7(3):e565. PubMed ID: 30666819
[TBL] [Abstract][Full Text] [Related]
17. [Role of associated alleles and hypomethylation status in the clinical expression of facioscapulohumeral muscular dystrophy].
Pikó H; Molnár MJ; Herczegfalvi A; Mayer P; Karcagi V
Orv Hetil; 2011 Sep; 152(39):1576-85. PubMed ID: 21920844
[TBL] [Abstract][Full Text] [Related]
18. Recurrent somatic mosaicism for D4Z4 contractions in a family with facioscapulohumeral muscular dystrophy.
Buzhov BT; Lemmers RJ; Tournev I; van der Wielen MJ; Ishpekova B; Petkov R; Petrova J; Frants RR; Padberg GW; van der Maarel SM
Neuromuscul Disord; 2005 Jul; 15(7):471-5. PubMed ID: 15935668
[TBL] [Abstract][Full Text] [Related]
19. Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats.
Statland JM; Donlin-Smith CM; Tapscott SJ; Lemmers RJ; van der Maarel SM; Tawil R
Neurology; 2015 Dec; 85(24):2147-50. PubMed ID: 26561289
[TBL] [Abstract][Full Text] [Related]
20. Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles.
Wohlgemuth M; Lemmers RJ; van der Kooi EL; van der Wielen MJ; van Overveld PG; Dauwerse H; Bakker E; Frants RR; Padberg GW; van der Maarel SM
Neurology; 2003 Oct; 61(7):909-13. PubMed ID: 14557558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
